It is the cache of ${baseHref}. It is a snapshot of the page. The current page could have changed in the meantime.
Tip: To quickly find your search term on this page, press Ctrl+F or ⌘-F (Mac) and use the find bar.

Adenosine A2a receptor agonists as regulators of inflammation: pharmac
skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

14804

Adenosine A2a receptor agonists as regulators of inflammation: pharmacology and therapeutic opportunities



Review

(9943) Total Article Views


Authors: Silvana Morello, Rosalinda Sorrentino, Aldo Pinto

Published Date August 2009 Volume 2009:2 Pages 11 - 17
DOI: http://dx.doi.org/10.2147/JRLCR.S4710

Silvana Morello, Rosalinda Sorrentino, Aldo Pinto

Department of Pharmaceutical Sciences, Biomedical Section, University of Salerno, Via Ponte don Melillo, 84084 Fisciano, Salerno, Italy

Abstract: A2a receptor (A2aR) plays an important role in the regulation of inflammatory and immune responses. The activation of PKA-dependent and/or -independent pathways are responsible for the downmodulation of inflammatory networks and tissue injury. Based on promising recent studies, selective A2aR agonists are under clinical investigations for a wide range of disorders, such as ischemia-reperfusion injury, chronic inflammation, and infectious diseases. Nevertheless, further studies are required to improve our understanding in the ability of A2a receptor agonists to reduce tissue damage during inflammation. Characterization of A2aR-induced signaling pathways will be useful for the development of novel therapeutic strategies in inflammatory/immune diseases.

Keywords: adenosine, A2a receptor, A2a receptor agonists, inflammation




Post to:
Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter


Readers of this article also read: